Raymond James Financial Inc. Makes New $53,000 Investment in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)
Raymond James Financial Inc. bought a new stake in shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor bought 24,992 shares of the company’s stock, valued at approximately $53,000. Several other hedge funds have also recently made changes to their positions in the business. […]
